Advent Life Sciences, Medicxi Ventures (Index Ventures’ life sciences vehicle) and Osage University Partners have led a £11m series-A for London-based biotechnology business Capella Bioscience.
Canadian GP previously owned around 20% of the listed education company
French bank BPCE mandated advisers to sell the Germany-based digital banking platform in 2018
ECI is currently investing from its ECI 11 fund, which closed on £700m on July 2018
GP will partner with NovaSparks CEO Luc Burgun to consolidate in a range of financial markets